20 years of the European IVF-monitoring Consortium registry: what have we learned? A comparison with registries from two other regions
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
STUDY QUESTION: How has the performance of the European regional register of the European IVF-monitoring Consortium (EIM)/European Society of Human Reproduction and Embryology (ESHRE) evolved from 1997 to 2016, as compared to the register of the Centres for Disease Control and Prevention (CDC) of the USA and the Australia and New Zealand Assisted Reproduction Database (ANZARD)? SUMMARY ANSWER: It was found that coherent and analogous changes are recorded in the three regional registers over time, with a different intensity and pace, that new technologies are taken up with considerable delay and that incidental complications and adverse events are only recorded sporadically. WHAT IS KNOWN ALREADY: European data on ART have been collected since 1997 by EIM. Data collection on ART in Europe is particularly difficult due to its fragmented political and legal landscape. In 1997, approximately 78.1% of all known institutions offering ART services in 23 European countries submitted data and in 2016 this number rose to 91.8% in 40 countries. STUDY DESIGN, SIZE, DURATION: We compared the changes in European ART data as published in the EIM reports (2001–2020) with those of the USA, as published by CDC, and with those of Australia and New Zealand, as published by ANZARD. PARTICIPANTS/MATERIALS, SETTING, METHODS: We performed a retrospective analysis of the published EIM data sets spanning the 20 years observance period from 1997 to 2016, together with the published data sets of the USA as well as of Australia and New Zealand. By comparing the data sets in these three large registers, we analysed differences in the completeness of the recordings together with differences in the time intervals on the occurrence of important trends in each of them. Effects of suspected over- and under-reporting were also compared between the three registers. X2 log-rank analysis was used to assess differences in the data sets. MAIN RESULTS AND THE ROLE OF CHANCE: During the period 1997–2016, the numbers of recorded ART treatments increased considerably (5.3-fold in Europe, 4.6-fold in the USA, 3.0-fold in Australia and New Zealand), while the number of registered treatment modalities rose from 3 to 7 in Europe, from 4 to 10 in the USA and from 5 to 8 in Australia and New Zealand, as published by EIM, CDC and ANZARD, respectively. The uptake of new treatment modalities over time has been very different in the three registers. There is a considerable degree of underreporting of the number of initiated treatment cycles in Europe. The relationship between IVF and ICSI and between fresh and thawing cycles evolved similarly in the three geographical areas. The freeze-all strategy is increasingly being adopted by all areas, but in Europe with much delay. Fewer cycles with the transfer of two or more embryos were reported in all three geographical areas. The delivery rate per embryo transfer in thawing cycles bypassed that in fresh cycles in the USA in 2012, in Australia and New Zealand in 2013, but not yet in Europe. As a result of these changing approaches, fewer multiple deliveries have been reported. Since 2012, the most documented adverse event of ART in all three registers has been premature birth (<37 weeks). Some adverse events, such as maternal death, ovarian hyperstimulation syndrome, haemorrhage and infections, were only recorded by EIM and ANZARD. LIMITATIONS, REASONS FOR CAUTION: The methods of data collection and reporting were very different among European countries, but also among the three registers. The better the legal background on ART surveillance, the more complete are the data sets. Until the legal obligation to report is installed in all European countries together with an appropriate quality control of the submitted data the reported numbers and incidences should be interpreted with caution. WIDER IMPLICATIONS OF THE FINDINGS: The growing number of reported treatments in ART, the higher variability in treatment modalities and the rising contribution to the birth rates over the last 20 years point towards the increasing impact of ART. High levels of completeness in data reporting have been reached, but inconsistencies and inaccuracies still remain and need to be identified and quantified. The current trend towards a higher diversity in treatment modalities and the rising impact of cryostorage, resulting in improved safety during and after ART treatment, require changes in the organization of surveillance in ART. The present comparison must stimulate all stakeholders in ART to optimize surveillance and data quality assurance in ART. STUDY FUNDING/COMPETING INTEREST(S): This study has no external funding and all costs are covered by ESHRE. There are no competing interests. TRIAL REGISTRATION NUMBER: N/A.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This may be due to an increase in births in women who had postponed motherhood, policy measures supporting families and working women, increased access to ART services, and the higher fertility rate among immigrant women (Organization for Economic Cooperation and Development (OECD), 2009; De Geyter et al., 2020).”
From Declining global fertility rates and the implications for family planning and family building: an IFFS consensus document based on a narrative review of the literature (2024) · cites this paper as De Geyter et al., 2020
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Not all countries collect ART data, in many countries not all clinics report, and data quality and validation are variable (De Geyter et al., 2020; Chambers et al., 2021).”
From Declining global fertility rates and the implications for family planning and family building: an IFFS consensus document based on a narrative review of the literature (2024) · cites this paper as De Geyter et al., 2020
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“An increasing number of countries have implemented policies, including improved access to infertility treatments, aiming to increase their fertility rate, restore the demographic pyramid, and increase the working age group’s positive economic impact (De Geyter et al., 2020; Central Intelligence Agency, The World Factbook: Field Listing—Total Fertility Rate, 2022).”
From Declining global fertility rates and the implications for family planning and family building: an IFFS consensus document based on a narrative review of the literature (2024) · cites this paper as De Geyter et al., 2020
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Some high-income countries have experienced a slight rebound in their TFR, partly because of childcare friendly policies (Organization for Economic Cooperation and Development, 2009; De Geyter et al., 2020; UNFPA, 2022).”
From Declining global fertility rates and the implications for family planning and family building: an IFFS consensus document based on a narrative review of the literature (2024) · cites this paper as De Geyter et al., 2020
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte
PALERMO, G. (1992) · The Lancet · doi:10.1016/0140-6736(92)92425-f · Cited by 3,586 · cited 13×
“Although the selection towards good prognosis cases may be linked to the higher delivery rates seen in the USA in conventional fresh IVF and ICSI, as discussed elsewhere (Kushnir et al. , 2016, 2017), other factors, such as the number of embryos transferred per cycle, may be involved in contributing to the observed hi…”
InfluentialBIRTH AFTER THE REIMPLANTATION OF A HUMAN EMBRYO
Steptoe, P. C., & Edwards, R. G. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92957-4 · Cited by 2,614 · cited 1×
“Although the first successful treatment with ART was carried out in Europe (Steptoe and Edwards, 1978), systematic data collection only started in Europe in 1997.”
Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification
Handyside, A. H., Kontogianni, E. H., Hardy, K., & Winston, R. M. L. (1990) · Nature · doi:10.1038/344768a0 · Cited by 1,604
The international glossary on infertility and fertility care, 2017
Zegers-Hochschild, F., Adamson, G. D., Dyer, S., Racowsky, C., de Mouzon, J., Sokol, R., Rienzi, L., Sunde, A., Schmidt, L., Cooke, I. D., et al. (2017) · Human Reproduction · doi:10.1093/humrep/dex234 · Cited by 1,320 · cited 2×
“The international glossary on definitions may help to standardize the reporting of adverse events (Zegers-Hochschild et al., 2017).”
Pandey, S., Shetty, A., Hamilton, M., Bhattacharya, S., & Maheshwari, A. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms018 · Cited by 786 · cited 1×
“This may be achieved by installing electronic healthcare records of individual couples or persons, which store all the complex data arising from ART and that ultimately can be used to add pregnancy-related and obstetric outcome data (Pandey et al. , 2012).”
ART in Europe, 2014: results generated from European registries by ESHRE†
De Geyter, C., Calhaz-Jorge, C., Kupka, M. S., Wyns, C., Mocanu, E., Motrenko, T., Scaravelli, G., Smeenk, J., Vidakovic, S., Goossens, V, et al. (2018) · Human Reproduction · doi:10.1093/humrep/dey242 · Cited by 639 · cited 1×
“Since then, annual reports have appeared covering the European activities in ART from 1997 to 2016, including a survey describing the trends over 15 years of ART in Europe (Ferraretti et al. , 2017).”
Self-citationZegers-Hochschild, F., Mansour, R., Ishihara, O., Adamson, G. D., de Mouzon, J., Nygren, K. G., & Sullivan, E. A. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.10.005 · Cited by 540
Self-citationSullivan, E. A., Zegers-Hochschild, F., Mansour, R., Ishihara, O., de Mouzon, J., Nygren, K. G., & Adamson, G. D. (2013) · Human Reproduction · doi:10.1093/humrep/det036 · Cited by 414
Self-citationKruse, C. S., Stein, A., Thomas, H., & Kaur, H. (2018) · Journal of Medical Systems · doi:10.1007/s10916-018-1075-6 · Cited by 403 · cited 2×
“Such an approach may be time-saving, by avoiding having to write extensive documentation and by improving the workflow, thereby resulting in better productivity (Kruse et al. , 2018).”
Adamson, G. D., de Mouzon, J., Chambers, G. M., Zegers-Hochschild, F., Mansour, R., Ishihara, O., Banker, M., & Dyer, S. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.06.039 · Cited by 385 · cited 2×
“The first aim of all national and supranational registers has traditionally been to record completely and accurately all possible treatment numbers and outcomes at different stages of the process and to come up with a coherent descriptive analysis (Adamson et al. , 2018).”
Research works printed but not linked: 3
- De Geyter, 2019, Assisted Reproductive Technology Surveillance
- Luke, 2019, Assisted Reproductive Technology Surveillance
- Toner, 2019, Assisted Reproductive Technology Surveillance, 172
Cited by
Items 201–208 of 208
Wang, Y., Xu, C., He, Y., Huang, J., Sun, Y. X., Lu, Y., & Wei, Z. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15145544
Lee, Y.-X., Su, P., Do, A. Q., Tzeng, C., Hu, Y.-M., Chen, L.-Y., Weng, Y., Wang, H.-C., & Lai, H. (2026) · Scientific Reports · doi:10.1038/s41598-026-61882-z
Zhang, Q., Li, S., Zhao, Z., Yu, T., Sun, K., Wang, B., & Yu, Y. (2026) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-026-09713-x
“The rapid development of assisted reproductive technology (ART) has brought hope of childbirth to more than 8 million infertile families worldwide [1, 2].”
Molinaro, P., Napoleoni, E., Alonso-Mayo, C., Pellicer, A., García-Velasco, J. A., & Cozzolino, M. (2026) · Fertility and Sterility · doi:10.1016/j.fertnstert.2026.08.002
Zhang, X., Li, Y., Fang, Y., Wang, D., Xu, S., Huang, X., Mao, G., & Li, D. (2026) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2026.105957
Erden, M., Telek, S. B., Yaralí, H., & Mümüşoğlu, S. (2026) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2026.105967
Fucci, R., Iserani, A., Irene, O., Cianchi, I., Badolato, L., Rizzello, F., Evangelisti, P., Angelis, D. D., Sciorio, R., Falcone, P., et al. (2026) · Reproductive Biology · doi:10.1016/j.repbio.2026.101289
Endara-Mina, J., Bermúdez-Gavilanes, J., Salazar, F.-R., Manzano-Gallegos, L. A., Figueroa-Andrade, J. M., Ortega-Parraga, D. N., González-Naranjo, D. E., Maldonado-Montalvan, F., Reytor-González, C., & Simancas‐Racines, D. (2026) · Frontiers in Reproductive Health · doi:10.3389/frph.2026.1974930
Metadata
- Authors
- De Geyter, C., Wyns, C., Calhaz-Jorge, C., de Mouzon, J., Ferraretti, A. P., Kupka, M., Nyboe Andersen, A., Nygren, K. G., & Goossens, V
- Affiliations
- Reproductive Medicine and Gynecological Endocrinology (RME), University Hospital, University of Basel, Basel, Switzerland
- Cliniques Universitaires Saint-Luc (BE)
- Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal
- Institut National de Santé et de la Recherche Médicale, Service de Gynécologie Obstétrique II et de Médecine de la Procréation, Groupe Hospitalier Cochin-Saint Vincent de Paul, Paris, France
- S.I.S.Me.R. Reproductive Medicine Unit, Bologna, Italy
- Fertility Center—Gynaekologicum, Hamburg, Germany
- The Fertility Clinic, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
- European Society of Human Reproduction and Embryology (BE)
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-11-14
- Volume
- 35
- Issue
- 12
- Pages
- 2832-2849
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- PMC
- PMC7744162
- OpenAlex
- W3100377772
- Cited by
- 195
- References
- 39
- Citations by year
- 2026: 15 · 2025: 37 · 2024: 36 · 2023: 55 · 2022: 35 · 2021: 17
- FWCI
- 23.59
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Human Reproduction (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by-nc)
- Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) (submittedVersion, other-oa)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- Funders
- European Society of Human Reproduction and Embryology
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Assisted Reproductive Technology and Twin Pregnancy
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Keywords
- assisted reproduction, ESHRE, registry data completeness, adverse events, technology adoption, Australia and New Zealand
- MeSH terms
- Australia, Europe, Female, Fertilization in Vitro, Humans, New Zealand, Pregnancy, Registries, Retrospective Studies, Pregnancy Rate, Sperm Injections, Intracytoplasmic, Reproductive Techniques, Assisted
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.